2,4-thiazolidinedione has been researched along with Arteriosclerosis, Coronary in 7 studies
thiazolidine-2,4-dione: structure in first source
1,3-thiazolidine-2,4-dione : A thiazolidenedione carrying oxo substituents at positions 2 and 4.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The aim of the present study was to assess the risk of overall mortality, coronary artery disease (CAD), and congestive heart failure (CHF) in patients with type 2 diabetes mellitus (T2DM) treated with metformin (MF) and an additional antidiabetic agent." | 3.83 | Risk of overall mortality and cardiovascular events in patients with type 2 diabetes on dual drug therapy including metformin: A large database study from the Cleveland Clinic. ( Kannan, S; Karafa, M; Matsuda, S; Pantalone, KM; Wells, BJ; Zimmerman, RS, 2016) |
| "Patients with type 2 diabetes mellitus are at increased risk for postangioplasty restenosis, which results from excessive intimal hyperplasia." | 2.42 | Thiazolidinedione regulation of smooth muscle cell proliferation. ( Bruemmer, D; Law, RE, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (85.71) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kannan, S | 1 |
| Pantalone, KM | 1 |
| Matsuda, S | 1 |
| Wells, BJ | 1 |
| Karafa, M | 1 |
| Zimmerman, RS | 1 |
| Geng, DF | 1 |
| Jin, DM | 1 |
| Wu, W | 1 |
| Wang, Z | 1 |
| Wang, JF | 1 |
| Raji, A | 1 |
| Plutzky, J | 2 |
| Bruemmer, D | 1 |
| Law, RE | 1 |
| Giles, TD | 1 |
| Castro Cabezas, M | 1 |
| Halkes, CJ | 1 |
| Erkelens, DW | 1 |
6 reviews available for 2,4-thiazolidinedione and Arteriosclerosis, Coronary
| Article | Year |
|---|---|
Effect of thiazolidinediones on in-stent restenosis in patients after coronary stenting: a meta-analysis of randomized controlled trials.
Topics: Angioplasty, Balloon, Coronary; Coronary Artery Disease; Coronary Restenosis; Humans; Hypoglycemic A | 2009 |
Insulin resistance, diabetes, and atherosclerosis: thiazolidinediones as therapeutic interventions.
Topics: Adipose Tissue; Animals; Chromans; Coronary Artery Disease; Diabetes Mellitus; Diabetic Angiopathies | 2002 |
The vascular biology of atherosclerosis.
Topics: Cholesterol, HDL; Coronary Artery Disease; Diabetes Mellitus, Type 2; Endothelium, Vascular; Humans; | 2003 |
Thiazolidinedione regulation of smooth muscle cell proliferation.
Topics: Blood Vessel Prosthesis Implantation; Cell Cycle Proteins; Cell Division; Coronary Artery Disease; D | 2003 |
The patient with diabetes mellitus and heart failure: at-risk issues.
Topics: Cardiac Output, Low; Coronary Artery Disease; Diabetes Mellitus; Endothelium, Vascular; Heart Failur | 2003 |
Obesity and free fatty acids: double trouble.
Topics: Chylomicrons; Coronary Artery Disease; Fatty Acids, Nonesterified; Humans; Hyperglycemia; Hyperlipid | 2001 |
1 other study available for 2,4-thiazolidinedione and Arteriosclerosis, Coronary
| Article | Year |
|---|---|
Risk of overall mortality and cardiovascular events in patients with type 2 diabetes on dual drug therapy including metformin: A large database study from the Cleveland Clinic.
Topics: Aged; Coronary Artery Disease; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Drug T | 2016 |